Treatment and Care
Treatment Centers and Clinical Services
Care Team
Patient And Family Support
Care Quality and Patient Safety
Patient Stories
For Adult Cancer Survivors
Browse by Cancer Type
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

New Patient Guide

Appointments & Second Opinions

New Patient? For appointments or second opinions: Adults: (877) 442-DFCI (442-3324) Children: (888) PEDI-ONC (733-4662) or complete the Appointment Request Form Online Specialty Consultations International Patients Referring Physician? To refer an adult patient: (877) 441-DFCI (441-3324) To refer a pediatric patient: (888) PEDI-ONC (733-4662) or complete the Patient Referral Form

Treatment and Care

Pediatric Treatment Centers and Clinical Services Care Team Patient And Family Support Care Quality and Patient Safety Patient Stories For Survivors of Childhood Cancer Browse by Cancer Type A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

New Patient Guide

Appointments & Second Opinions

New Patient? For appointments or second opinions: Adults: (877) 442-DFCI (442-3324) Children: (888) PEDI-ONC (733-4662) or complete the Appointment Request Form Your Child's Care Team For International Patients Referring Physician? To refer an adult patient: (877) 441-DFCI (441-3324) To refer a pediatric patient: (888) PEDI-ONC (733-4662) or complete the Patient Referral Form

Home
Newsroom
News Releases

News Releases

Search News

Date Range

From:

To:

clear all

Tags

Antibody Appointments BasicResearch BloodDonation BostonRedSox BrainTumors BreastCancer CervicalCancer chemotherapy ChildhoodCancer ColonCancer CopingWithCancer Development Disparities DrugResistance EducationDevelopment EGFR EndOfLife Exercise Genetics Genomics GraftVersusHost Grants GynecologicCancers HeadNeckCancers Honors Hormones Imaging ImmuneSystem Influenza JimmyFund KinaseInhibitor KraftCenter Leukemia LiverCancer LungCancer Lymphoma Melanoma MultipleMyeloma NewEnglandPatriots Nursing Nutrition OralCancer OvarianCancer PancreaticCancer PanMassChallenge Partnerships PatientEducation PatientSafety PatientSupport PatientVideos PlateletDonation PopulationScience Prevention ProstateCancer Radiation Sarcoma SkinCancer Smoking StemCellTransplant Survivorship TargetedTherapy TranslationalResearch YawkeyCenter

Archives

Email
Print
Share
Text

Highlight Glossary Terms

News tagged ‘DrugResistance’ clear

Sorted by:
Date
Title

Regorafenib was found to reduce the risk of disease progression or death by more than 70 percent in patients whose tumors had become resistant to Gleevec and Sutent.

Tags: DrugResistance, Sarcoma, TargetedTherapy

New drug strategy attacks resistant leukemia and lymphoma
- May 29, 2012

Researchers at Dana-Farber/Children's Hospital Cancer Center have created a peptide that overcomes drug resistance and reactivates programmed cell death in recurrent blood cancers.

Tags: chemotherapy, DrugResistance, Leukemia, Lymphoma

Research yields new agent for some drug-resistant, non-small cell lung cancers
- December 23, 2009

Researchers have halted non-small cell lung tumors resistant to Iressa and Tarceva with a newly constructed compound that may also have fewer side effects.

Tags: DrugResistance, LungCancer

Showing 1-3 of 3 items